Please use this identifier to cite or link to this item:
http://repo.knmu.edu.ua/handle/123456789/23474
Title: | Nesfatin-1 activity in hypertensive obese patients changes with the duration of hypertension |
Authors: | Візір, Марина Олександрівна Vizir, Maryna Визир, Марина Александровна |
Keywords: | nesfatin-1 cardiometabolic risk obesity duration of hypertension |
Issue Date: | 25-May-2019 |
Publisher: | European Society of Cardiology |
Citation: | Vizir M. Nesfatin-1 activity in hypertensive obese patients changes with the duration of hypertension / М. Vizir // European Journal of Heart Failure. 2019. – Vol. 21, suppl. S1. – P. 133. |
Abstract: | Nesfatin-1 was discovered in 2006 as a satiety peptide produced by hypothalamus and adipose tissue mainly. It was found that activity of nesfatin-1 may be related to the occurrence of hypertension, obesity, type 2 diabetes mellitus and thereby affect the cardiometabolic risk. However, the mechanisms which lead to progressive deterioration after long-term hypertension remain unclear. |
URI: | https://repo.knmu.edu.ua/handle/123456789/23474 |
Appears in Collections: | Наукові праці. Кафедра внутрішньої медицини № 1 |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.